Intact Investment Management Inc. Trims Stake in Boston Scientific Co. (NYSE:BSX)
Intact Investment Management Inc. cut its position in Boston Scientific Co. (NYSE:BSX – Free Report) by 18.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,900 shares of the medical equipment provider’s stock after selling 2,300 shares during the […]
More Stories
Sysco (NYSE:SYY) Price Target Raised to $88.00
Sysco (NYSE:SYY – Free Report) had its price target increased by JPMorgan Chase & Co. from $85.00 to $88.00 in...
Trio-Tech International (NYSE:TRT) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Trio-Tech International (NYSE:TRT – Free Report) in a research report released on Monday morning....
SL Green Realty (NYSE:SLG) Upgraded to “Inline” by Evercore ISI
Evercore ISI upgraded shares of SL Green Realty (NYSE:SLG – Free Report) from an underperform rating to an inline rating...
StockNews.com Upgrades Trade Desk (NASDAQ:TTD) to “Buy”
StockNews.com upgraded shares of Trade Desk (NASDAQ:TTD – Free Report) from a hold rating to a buy rating in a...
Morgan Stanley Trims Range Resources (NYSE:RRC) Target Price to $31.00
Range Resources (NYSE:RRC – Free Report) had its price objective decreased by Morgan Stanley from $33.00 to $31.00 in a...
Intra-Cellular Therapies (NASDAQ:ITCI) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a research report report...